Search research publications and outputs

  1. STAT3 inhibition with Galiellalactone effectively targets the prostate cancer stem-like cell population."

    Canesin, G., Maggio, V., Palominos, M., Stiehm, A., Contreras, H. R., Castellón, E. A., Morote, J., Paciucci, R., Maitland, N. J., Bjartell, A. & Hellsten, R., 18 Aug 2020

    Article in Scientific Reports